![Graphic with a dark blue background and image of a light blue vortex tunnel on the left. On the right, there is white text that says From Our Perspective.](https://public4.pagefreezer.com:443/content/FDA/11-10-2023T12:49/https://www.fda.gov/files/styles/medium_3/public/From%20Our%20Perspective%201600x900%20Graphic.png?itok=5p2ywGt7)
CDER continues to take measures to combat the overdose crisis
Efforts include a new guidance and updated warnings for stimulants
Efforts include a new guidance and updated warnings for stimulants
We will discuss Roadmap 2.0 research priorities and ongoing projects
Software could help people take medication more safely, effectively
Learn how the agency uses science and data to ensure drug safety, quality and efficacy
Topics include case-studies of intramural and extramural research
Therapeutic equivalence code changed for Accord’s tacrolimus
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.